The most common hereditary tumours panel (31 gene sequencing with NGS): run time up to 4 weeks

Description:

The most common hereditary tumours panel – 31 gene sequencing with NGS (Next-Generation Sequencing). Detects changes in 31 genes associated with hereditary tumour syndromes.

The advantage of this panel is its wide diagnostic capabilities, which, when suspected of hereditary tumour syndromes, can not only determine changes in certain syndrome-related genes, but also expand the range of tested genes, including genes, whose changes can occur phenotypically as tumours less typical for the syndrome. This panel is recommended for hereditary breast / ovarian cancer, as well as in the case of various other tumours, such as Lynch syndrome, or hereditary nonpolyposis colorectal cancer, Li-Fraumeni syndrome, Cowden syndrome, Multiple endocrine neoplasia (MEN), various kinds of hereditary intestinal polyposis with high risk of malignancies, Neurofibromatosis type 1 (NF1). In terms of cost-benefit, the analysis is comparable to the complete single gene sequencing, while the information obtained is much broader and more comprehensive.

The sample collection kit will be sent to the specified Omniva parcel machine. Then you will send the sample back to us (with our postage paid) and we will perform the test.

• The test will be completed within 4 weeks.
• The results will be sent to you by email encoded.

Genetic tests are performed for persons older than 18 years.

How It Works?

LATAK accreditation